Sign in
4

Changes in Ownership

Citius Pharmaceuticals, Inc. Filed Acc 0001213900-20-030794

Options or other derivatives

  • President and CEO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HOLUBIAK MYRON Z · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-06 Grant or award : show line 1 in the form Options to Purchase Common Stock +200,000 200,000 D
Loading xslF345X03/ownership.xml…